|
1. Ridgeway EE.
Periodontal disease: diagnosis and management.
J Am Acad Nurse Pract. 2000;12:79-84.
https://doi.org/10.1111/j.1745-7599.2000.tb00171.x
PMid:11033686
|
|
|
|
2. Loesche WJ.
Bacterial mediators in periodontal disease.
Clin Infect Dis.1993;16:S203-S21.
https://doi.org/10.1093/clinids/16.Supplement_4.S203
PMid:8324120
|
|
|
|
|
3.
Souza JA, Rossa C Jr, Garlet GP, Nogueira AV,
Cirelli JA. Modulation of host
cell signaling pathways as a therapeutic
approach in periodontal disease. J Appl Oral
Sci. 2012;20:128-38.
https://doi.org/10.1590/S1678-77572012000200002
PMid:22666826 PMCid:PMC3894752
|
|
|
|
|
4. Okada H, Murakami
S. Cytokine expression in periodontal health
and disease. Crit
Rev Oral Biol Med. 1998;9:248-66.
https://doi.org/10.1177/10454411980090030101
PMid:9715365
|
|
|
|
|
5. Albandar JM. Global
risk factors and risk indicators for
periodontal diseases. Periodontol 2000. 2002;29:177-206.
PMid:12102708
|
|
|
|
|
6. Paquette DW,
Williams RC. Modulation of host inflammatory
mediators as a treatment strategy for
periodontal diseases. Periodontol
2000. 2000;24:239-52.
https://doi.org/10.1034/j.1600-0757.2000.2240112.x
PMid:11276870
|
|
|
|
|
7. Noguchi K, Ishikawa
I. The roles of cyclooxygenase-2 and
prostaglandin E2 in periodontal disease. Periodontol
2000. 2007;43:85-101.
https://doi.org/10.1111/j.1600-0757.2006.00170.x
PMid:17214837
|
|
|
|
|
8. Yucel-Lindberg T,
Ahola H, Nilsson S, Carlstedt-Duke J, Modéer T.
Interleukin-1 beta induces expression of
cyclooxygenase-2 mRNA in human gingival
fibroblasts. Inflammation.
1995;19:549-60.
https://doi.org/10.1007/BF01539135
PMid:8543370
|
|
|
|
|
9.
Andriankaja OM, Barros SP, Moss K, Panagakos
FS, DeVizio W, Beck J, et al. Levels of serum interleukin (IL)-6 and
gingival crevicular fluid of IL-1β and prostaglandin E2 among non-smoking
subjects with gingivitis and type 2 diabetes. J
Periodontol. 2009;80:307-16.
https://doi.org/10.1902/jop.2009.080385
PMid:19186972
|
|
|
|
|
10. Thunell DH, Tymkiw
KD, Johnson GK, Joly S, Burnell KK, Cavanaugh
JE, et al. A multiplex immunoassay demonstrates
reductions in gingival crevicular fluid
cytokines following initial periodontal
therapy. J
Periodontal Res.2010;45:148-52.
https://doi.org/10.1111/j.1600-0765.2009.01204.x
PMid:19602112 PMCid:PMC5405696
|
|
|
|
|
11. Radogna F,
Diederich M, Ghibelli, L. Melatonin: a
pleiotropic molecule regulating inflammation. Biochem
Pharmacol. 2010;80:1844-52.
https://doi.org/10.1016/j.bcp.2010.07.041
PMid:20696138
|
|
|
|
|
12.
Reiter RJ, Calvo JR, Karbounik M, Qi W, Tan DX,
Fuentes-Broto L. Melatonin: a multitasking
molecule. Prog Brain Res. 2010; 181: 127-51.
https://doi.org/10.1016/S0079-6123(08)81008-4
|
|
|
|
|
13. Mozaffari S,
Abdollahi M. Melatonin, a promising supplement
in inflammatory bowel disease: a comprehensive
review of evidences. Curr
Pharm Des. 2011;17:4372-78.
https://doi.org/10.2174/138161211798999357
PMid:22204435
|
|
|
|
|
14. Tengattini S,
Reiter RJ, Tan DX, Terron MP, Rodella LF,
Rezzani, R. Cardiovascular diseases: protective
effects of melatonin, J Pineal Res. 2008;44:16-25.
PMid:18078444
|
|
|
|
|
15.
Cutando A, Gómez-Moreno G, Arana C, Acuña-Castroviejo
D, Reiter RJ. Melatonin: potential
functions in the oral cavity. J Periodontol.
2007;78:1094-102.
https://doi.org/10.1902/jop.2007.060396
PMid:17539724
|
|
|
|
|
16. American Diabetes
Association. Diagnosis and classification of
diabetes mellitus. Diabetes Care. 2010;33:S62-S69.
https://doi.org/10.2337/dc10-S062
PMid:20042775 PMCid:PMC2797383
|
|
|
|
|
17. Löe H, Silness, J.
Periodontal Disease in pregnancy. I. Prevalence
and severity. Acta Odontol Scand. 1963;21:533-51.
https://doi.org/10.3109/00016356309011240
PMid:14121956
|
|
|
|
|
18. Fain JN. Release
of interleukins and other inflammatory
cytokines by human adipose tissue is enhanced
in obesity and primarily due to the nonfat
cells. Vitam
Horm. 2006;74:443-77.
https://doi.org/10.1016/S0083-6729(06)74018-3
PMid:17027526
|
|
|
|
|
19. Zhong Y, Slade GD,
Beck JD, Offenbacher S. Gingival crevicular
fluid interleukin-1beta, prostaglandin E2 and
periodontal status in a community population. J
Clin Periodontol. 2007;34:285-93.
https://doi.org/10.1111/j.1600-051X.2007.01057.x
PMid:17378884
|
|
|
|
|
20. Bulut U,
Develioglu H, Taner IL, Berker E. Interleukin-1
beta levels in gingival crevicular fluid in
type 2 diabetes mellitus and adult
periodontitis. J
Oral Sci. 2001;43:171-7.
https://doi.org/10.2334/josnusd.43.171
PMid:11732737
|
|
|
|
|
21.
Engebretson SP, Hey-Hadavi J, Ehrhardt FJ, Hsu
D, Celenti RS, Grbic JT et al. Gingival crevicular fluid levels of
interleukin-1beta and glycemic control in
patients with chronic periodontitis and type 2
diabetes. J
Periodontol. 2004;75:1203-8.
https://doi.org/10.1902/jop.2004.75.9.1203
PMid:15515334
|
|
|
|
|
22.
Duarte PM, de Oliveira MC, Tambeli CH, Parada
CA, Casati MZ, Nociti FR Jr. Overexpression of interleukin-1beta and
interleukin-6 may play an important role in
periodontal breakdown in type 2 diabetic
patients. J
Periodontal Res. 2007;42:377-81.
https://doi.org/10.1111/j.1600-0765.2006.00961.x
PMid:17559636
|
|
|
|
|
23. Murayama R,
Kobayashi M, Takeshita A, Yasui T, Yamamoto M.
MAPKs, activator protein-1 and nuclear factor-κB mediate production of interleukin-1β-stimulated cytokines, prostaglandin E
and MMP-1 in human periodontal ligament cells. J
Periodontal Res. 2011;46:568-75.
https://doi.org/10.1111/j.1600-0765.2011.01374.x
PMid:21615409
|
|
|
|
|
24.
Kida Y, Kobayashi M, Suzuki T, Takeshita A,
Okamatsu Y, Hanazawa S, et al. Interleukin-1 stimulates cytokines,
prostaglandin E2 and matrix metalloproteinase-1
production via activation of MAPK/AP-1 and NF-kappaB
in human gingival fibroblasts. Cytokine.
2005;29:159-68.
https://doi.org/10.1016/j.cyto.2004.10.009
PMid:15652448
|
|
|
|
|
25. Deschner J, Arnold
B, Kage A, Zimmermann B, Kanitz V, Bernimoulin,
JP. Suppression of interleukin-10 release from
human periodontal ligament cells by
interleukin-1beta in vitro. Arch
Oral Biol. 2000;45:179-83.
https://doi.org/10.1016/S0003-9969(99)00120-X
PMid:10716623
|
|
|
|
|
26.
Nukaga J, Kobayashi M, Shinki T, Song H, Takada
T, Takiguchi T, et al. Regulatory effects of
interleukin-1beta and prostaglandin E2 on
expression of receptor activator of nuclear
factor-kappaB ligand in human periodontal
ligament cells. J
Periodontol. 2004;75:249-59.
https://doi.org/10.1902/jop.2004.75.2.249
PMid:15068113
|
|
|
|
|
27.
Gómez-Moreno G, Cutando-Soriano A, Arana C,
Galindo P, Bolaños J, Acuña-Castroviejo D, et
al. Melatonin expression
in periodontal disease. J Periodont Res.
2007;42:536-40.
https://doi.org/10.1111/j.1600-0765.2007.00978.x
PMid:17956466
|
|
|
|
|
28. Goutoudi P, Diza
E, Arvanitidou M. Effect of periodontal therapy
on crevicular fluid interleukin-1beta and
interleukin-10 levels in chronic periodontitis.
J Dent. 2004;32: 511-20.
https://doi.org/10.1016/j.jdent.2004.04.003
PMid:15304296
|
|
|
|
|
29. Gamonal J, Acevedo
A, Bascones A, Jorge O, Silva A. Levels of
interleukin-1 beta, -8, and -10 and RANTES in
gingival crevicular fluid and cell populations
in adult periodontitis patients and the effect
of periodontal treatment. Periodontol.
2000;71:1535-45.
PMid:11063385
|
|